Learn about how you can support SENS Research Foundation's work through the 2017 "Project for Awesome" video event.
Job opportunity posting: SENS Research Foundation is looking to hire a new Information Technology technician who specializes in network engineering and systems administration.
Job opportunity posting: SENS Research Foundation is seeking an executive to lead its campaign to develop high value donations.
Press Release: New Study Funded by SENS Research Foundation Sheds Greater Light on Diabetes and the Aging Process
Calico / AbbVie collaboration announcement demonstrates growth of the Rejuvenation Biotechnology industryPosted by Mike Kope, CEO on September 04, 2014 | Outreach
Reuter's announced today the launch of a Calico/Abbvie agreement. SENS Research Foundation congratulates U.S. drugmaker AbbVie Inc and Calico on the excellent news of their collaboration.
SENS Research Foundation is pleased to announce that its Board has authorized a bridge loan to Arigos Biomedical, Inc.
Today, Larry Page announced that Apple and Genentech chair Art Levinson will lead Calico, a Google initiative focused on challenges of age-related disease. TIME asked SRF CSO Aubrey de Grey for his take, posted in conjunction with the breaking news.
Summary of the SENS6: Reimaging Aging Conference
As a research-based outreach organization, SENS Research Foundation couples its strong scientific programs with an important focus on spreading the word about its cause. That focus is the reason that we’re so excited to announce our new Reimagine Aging celebrity campaign.
Mountain View, CA - The world’s leading series of conferences dedicated to the prevention and treatment of the diseases of aging using regenerative medicine will hold its next installment later this year. The conference, entitled “SENS6: Reimagine Aging,” will be held from September 3-7, 2013 at Queens’ College, Cambridge, UK. As part of the biennial SENS conference series, SENS6 will be presented by SENS Research Foundation (SRF), a biomedical research charity.
While antibiotics have long provided broad-spectrum treatments for bacterial infections, antiviral drugs have failed to offer protection that is nearly as wide. Dr. Todd Rider, who will be speaking at SENS6, is working to change that.
Many diseases mirror some aspect of aging. Multiple sclerosis (MS), which is caused by the loss of the myelin coating that protects nerve cells in the brain and spinal cord, is one example: myelin is also lost and poorly replaced in normal aging. Scientists like Cambridge’s Dr. Robin Franklin, a SENS6 speaker, are working hard to repair this damage.
Introduction to Dr. Alan Russell and his work crossing the boundaries of chemical engineering, biology, and materials science.
The SENS6 conference’s keynote address will be delivered by Dr. George Church, a researcher widely considered a luminary in modern biotechnology with over 300 publications to date.
While SENS6 will feature presentations by many esteemed and experienced researchers, Dr. Felipe Sierra stands out for his unifying vision and deep involvement in aging research.
The SENS6 conference will feature talks by many researchers who are leaders in their fields. One such speaker is the McGowan Institute for Regenerative Medicine’s Dr. Eric Lagasse.
The genomic revolution stands poised to transform cancer therapy and many areas of medicine. SENS Research Foundation-funded researchers outline what needs to be done to take raw results and integrate them into reliable clinical practice.
Rescue Assist, Inc., a company developing a robotic product that readily maneuvers through debris and will help rescue workers find disaster survivors, has pledged 7% of its profits to SENS Research Foundation.
Dr. Aubrey de Grey, Chief Science Officer of SENS Research Foundation, has been interviewed by Daniel Levine of The Burrill Report.
Dr. Aubrey de Grey, SENS Research Foundation’s Chief Science Officer, debated Dr. Richard Faragher, Chair of the British Society for Research on Ageing and Professor of Biological Gerontology at the University of Brighton, at Oxford’s Sheldonian Theatre on February 19. SENS Research Foundation is proud to have been a sponsor of this event, and would like to thank the Oxford University Society of Biomedical Sciences (OUSBMS) for hosting it.
Mike Kope's message welcoming visitors to our newly-revised site, relaunched in early 2013. It all centers around a new tagline: reimagine aging. Of course we are still "advancing rejuvenation biotechnologies" just as vigorously as when we carried that tagline over the last couple years.
SENS Research Foundation celebrated its progress in 2012 with a party at Evidence Studios in Los Angeles on December 20.
The University of Delaware's Socratic Club will be hosting Dr. Aubrey de Grey on Tuesday, October 2.
Your vote could mean $10,000 or more for SENS Foundation to put toward our groundbreaking research into effectively mitigating age-related disease. To vote, simply visit SENS Foundation's official Chase Community Giving page.
This month, a paper reporting results from the LysoSENS project that SENS Foundation funds at Rice University will be published in the printed edition of Biotechnology and Bioengineering. The research that produced these results was primarily performed by Dr. Jacques Mathieu, and focused on identifying enzymes that can degrade or modify 7-ketocholesterol, a root cause of atherosclerosis; such enzymes could ultimately be used as a new class of regenerative therapies to prevent and reverse heart disease.
In this series of four interviews, suitable for viewers with or without a scientific background, Dr de Grey explains the key ideas, initial results and projected outcomes of the SENS program, and explains how SENS Research Foundation operates to educate and inform the public about the conceptual and practical advantages of rejuvenation biotechnology.
The "Debate of the Ages", hosted by the Oxford University Scientific Society and featuring SENS Foundation's Chief Science Officer Dr Aubrey de Grey and Oxford's Professor Colin Blakemore, has been recorded courtesy of SENS Foundation and is now available via our YouTube channel.
"This house wants to defeat ageing entirely"; Dr de Grey to debate Professor Colin Blakemore in Oxford, April 25thPosted by Daniel Kimbel on April 17, 2012 | Outreach
Oxford University Scientific Society is hosting a debate on Wednesday, 25th April, 2012. Dr. Aubrey de Grey will propose the motion "This house wants to defeat ageing entirely" and Professor Colin Blakemore will be opposing. The debate will be chaired and moderated by Professor Sir Richard Peto. This debate will address whether it is feasible and appropriate to consider ageing as a target of decisive medical intervention, raising the possibility of substantial extension of human lifespan.